亚宝药业：第九届董事会第十二次会议决议公告

Core Viewpoint - The company announced the approval of its profit distribution plan for the third quarter of 2025 and the convening of the first extraordinary shareholders' meeting in 2026 [2] Group 1 - The company's ninth board of directors held its twelfth meeting to review and approve the profit distribution plan [2] - The company is preparing for the first extraordinary shareholders' meeting in 2026 [2]